Osteogenic potential of adipose stem cells on hydroxyapatite-functionalized decellularized amniotic membrane

• Published in: Colloids and surfaces, B, Biointerfaces Vol. 240; p. 113974
• Main Authors: Firouzeh, Arezoo, Shabani, Iman, Karimi-Soflou, Reza, Shabani, Azadeh
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.08.2024
• Subjects: 10X SBF; Amniotic membrane; Bone tissue engineering; Coated amniotic membrane; Decellularization; Hydroxyapatite; Amniotic membrane; 10X SBF; Hydroxyapatite; Coated amniotic membrane; Bone tissue engineering; Decellularization
• ISSN: 0927-7765; 1873-4367; 1873-4367
• DOI: 10.1016/j.colsurfb.2024.113974

Amniotic membrane (AM) is an attractive source for bone tissue engineering because of its low immunogenicity, contains biomolecules and proteins, and osteogenic differentiation properties. Hydroxyapatite is widely used as bone scaffolds due to its biocompatibility and bioactivity properties. The aim of this study is to design and fabricate scaffold based on hydroxyapatite-coated decellularized amniotic membrane (DAM-HA) for bone tissue engineering purpose. So human amniotic membranes were collected from healthy donors and decellularized (DAM). Then a hydroxyapatite-coating was created by immersion in 10X SBF, under variable parameters of pH and incubation time. Hydroxyapatite-coating was characterized and the optimal sample was selected. Human adipose-derived mesenchymal stem cell behaviors were assessed on control, amniotic membrane, and coated amniotic membrane. The results of the SEM, MTT assay, and Live-Dead staining showed that DAM and DAM-HA support cell adhesion, viability and proliferation. Osteogenic differentiation was evaluated by assessment of alkaline phosphatase activity and expression of osteogenic markers. Maximum gene expression values compared to control occurred in 14 days for alkalin phosphatase, while the highest values for osteocalcin and osteopontin in 21 days. These gene expression values in DAM and DAM-HA for alkalin phosphatase is 6.41 and 8.47, for osteocalcin is 3.95 and 5.94 and for osteopontin is 5.59 and 9.9 respectively. The results of this study indicated DAM supports the survival and growth of stem cells. Also, addition of hydroxyapatite component to DAM promotes osteogenic differentiation while maintaining viability. Therefore, hydroxyapatite-coated decellularized amniotic membrane can be a promising choice for bone tissue engineering applications. [Display omitted] •Amniotic membrane is a suitable source for bone tissue engineering application.•Prepared a homogeneous hydroxyapatite coating through immersion in 10X SBF.•Hydroxyapatite coated amniotic membrane promoted the viability of the cells.•Hydroxyapatite coated amniotic membrane promotes osteogenic differentiation.